Notice of Intent to Sole Source - BR2 Bilirubin Stat-Analyzer, Total and Direct Bilirubin Kit and Preventive Maintenance

Project ID: HT941026N0031 FederalOpportunitiesSpecial Notice

Overview

Agency	Defense Health Agency
Deadline	03/04/26
Posted	02/24/26
Estimated Value	Not Provided
Set Aside	None
NAICS	334516 - Analytical Laboratory Instrument Manufacturing
PSC	6630 - Chemical Analysis Instruments
Location	JBPHH, HI 96860 United States

Description

Primary Latest Change

Notice of Intent to Sole Source HT941026N0031

THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE SUPPLY CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division West (HCD-W), intends to award a firm fixed price supply and preventive maintenance purchase for BR2 Bilirubin Stat-Analyzer, Total and Direct Bilirubin Kit, Instrument Installation and Training Bundle, plus 4 year Preventive Maintenance Service for use in the Naval Health Clinic (NHC) Hawaii, Kaneohe Bay Laboratory in accordance with the Federal Acquisition Regulation Revolutionary (FAR) Overhaul 13.101(b):

Two Technology Way

Norwood, Massachusetts, 02062 UEI: LCFDHTGXB5J3 Cage: 1JU03 The North American Industry Classification System (NAICS) code for this requirement is 334516 Analytical Laboratory Instrument Manufacturing; the business size standard is 1000 (in employees). The Product Service Code (PSC) is 6630 - Chemical Analysis Instruments. The objective of this sole source award is to procure equipment, installation and preventive maintenance of BR2 Billirubin Stat Analyzer Total Kit for Naval Health Clinic (NHC) Hawaii, Kaneohe Bay Laboratory. Nova Biomedical is the sole manufacturer of the BR2 Bilirubin Stat Analyzer and its proprietary Bilirubin Test Kits with no authorized provider of maintenance, repair, and service for this system. There is no reasonable expectation of receiving quotes from two or more small businesses. The proposed acquisition strategy is to justify as an Other Than Full and Open procurement on a sole source basis.

Period of Performance

Delivery: 4/1/2026 - Include first year warranty for service Option Year 1 (Service): 4/1/2027 -3/31/2028 Option Year 2 (Service): 4/1/2028 -3/31/2029 Option Year 3 (Service): 4/1/2029 -3/31/2030 Option Year 4 (Service): 4/1/2030 -3/31/2031 Nova Biomedical is the only source that can meet the Government's minimum requirements to provide the requested equipment, installation and preventive maintenance mentioned above at Naval Health Clinic (NHC) Hawaii, Kaneohe Bay Laboratory. This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the required equipment and preventive maintenance. Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order. If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to Denise Bond at denise.d.bond.civ@health.mil The closing date for challenges is no later than 1000 Pacific Daylight Time, Wednesday 04 March 2026. NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.

Summary (Newest Update)

Background The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division – West (HCD-W), intends to award a firm fixed price supply and preventive maintenance contract for the BR2 Bilirubin Stat-Analyzer and associated products. The objective is to procure equipment, installation, and preventive maintenance for the Naval Health Clinic (NHC) Hawaii, Kaneohe Bay Laboratory. Nova Biomedical Corporation, located at Two Technology Way, Norwood, Massachusetts, is the sole manufacturer of the BR2 Bilirubin Stat Analyzer and its proprietary Bilirubin Test Kits. There are no authorized providers for maintenance, repair, and service for this system, making this a sole source procurement. Work Details The contract includes the following items: - BR2 Bilirubin Stat-Analyzer - Total and Direct Bilirubin Kit - Instrument Installation and Training Bundle - 4-year Preventive Maintenance Service. Period of Performance Delivery is scheduled for April 1, 2026, which includes the first year warranty for service. Option years for service are as follows: - Option Year 1: April 1, 2027 - March 31, 2028 - Option Year 2: April 1, 2028 - March 31, 2029 - Option Year 3: April 1, 2029 - March 31, 2030 - Option Year 4: April 1, 2030 - March 31, 2031. Place of Performance Naval Health Clinic (NHC) Hawaii, Kaneohe Bay Laboratory.

Contacts

Contact name	Denise Bond
Contact email	denise.d.bond.civ@health.mil
Contact phone	(210) 868-4974
Secondary contact name	CHA-ON Gordon
Secondary contact email	cha-on.p.gordon2.civ@health.mil
Secondary contact phone	(726) 203-0109